Abstract:Objective Preeclampsia is a common and serious complication of pregnancy, posing a threat to maternal and fetal safety due to the lack of effective biomarkers and treatment strategies. This study aimed to identify potential biomarkers that can be used to predict preeclampsia and identify the molecular mechanisms of preeclampsia pathogenesis and drug prediction at the transcriptome level. Methods We analyzed differential expression genes (DEGs) in preeclampsia and non-preeclampsia groups in the GSE75010 dataset, cross-linking with extracted inflammatory response-related genes to obtain differentially expressed inflammation-related genes (DINRGs). Enrichment analysis and protein-protein interaction (PPI) networks were constructed to understand the functions and enrichment pathways. Machine learning models were used to identify key genes associated with preeclampsia and build a nomogram in the training set, which was validated in the validation set. The R package RcisTarget was used to predict transcription factors, and Cytoscape was used to construct miRNA-mRNA pathways, which could identify the molecular mechanisms. Then, we conducted molecular docking of the obtained key genes INHBA (inhibin subunit beta A), OPRK1 (opioid receptor kappa 1), and TPBG (trophoblast glycoprotein), as well as predicted transcription factors with drug molecules. Additionally, the CIBERSORT method explored the differences in immune cell infiltration between preeclampsia and non-preeclampsia samples based on the GSE75010 dataset. Results A total of 69 DINRGs associated with preeclampsia patients were screened. INHBA, OPRK1 , and TPBG were the key genes based on machine learning models. A nomogram for prediction was further constructed, and the receiver operating curves (ROCs) showed good performance. Based on the transcriptome level of key genes, we proposed that RELA-miR-548K/miR-1206-TPBG may be a potential RNA regulatory pathway regulating the progression of early preeclampsia. Molecular docking suggested the effectiveness of curcumin in the treatment of preeclampsia. Additionally, regulatory T cells (Tregs) and resting mast cells were significantly different between the two groups. Conclusion In summary, we identified three key inflammation-associated genes, namely INHBA, OPRK1 , and TPBG , which can be used as potential genetic biomarkers for preeclampsia prediction and treatment, and established a nomogram as a predictive model. Additionally, we provided insights into the mechanisms of preeclampsia development at the transcriptome level and performed corresponding drug predictions.

Development and validation of preeclampsia predictive models using key genes from bioinformatics and machine learning approaches

Detection and assessment of immune and stromal related risk genes to predict preeclampsia: A bioinformatics analysis with dataset

Potential Of Immune-Related Genes As Biomarkers For Diagnosis And Subtype Classification Of Preeclampsia

Development and Validation of Nomograms to Predict Clinical Outcomes of Preeclampsia

Bioinformatics-based Identification of Mirna-, Lncrna-, and Mrna-Associated Cerna Networks and Potential Biomarkers for Preeclampsia.

Bioinformatics Methods in Biomarkers of Preeclampsia and Associated Potential Drug Applications

Identification and validation of an angiogenesis-related signature associated with preeclampsia by bioinformatic analysis

Identification of Lupus-Associated Genes in the Pathogenesis of Pre-eclampsia Via Bioinformatic Analysis

Identification and Verification of Diagnostic Biomarkers Based on Mitochondria-Related Genes Related to Immune Microenvironment for Preeclampsia Using Machine Learning Algorithms

An integrative bioinformatics analysis of microarray data for identifying hub genes as diagnostic biomarkers of preeclampsia

Machine Learning and Bioinformatics Framework Integration Reveal Potential Characteristic Genes Related to Immune Cell Infiltration in Preeclampsia.

Identification of hub glutamine metabolism-associated genes and immune characteristics in pre-eclampsia

Identification Of Key Genes In Preeclampsia-Associated Trophoblast Cells Using Bioinformatics Analysis

Identifying Key Genes and Drug Screening for Preeclampsia Based on Gene Expression Profiles

Inflammation in Preeclampsia: Genetic Biomarkers, Mechanisms, and Therapeutic Strategies

Integrated analysis of multiple microarray studies to identify novel gene signatures in preeclampsia

Construction of a pathway-level model for preeclampsia based on gene expression data

Insights into preeclampsia: a bioinformatics approach to deciphering genetic and immune contributions

Single-Cell RNA Sequencing and Microarray Analysis Reveal the Role of Lipid-Metabolism-Related Genes and Cellular Immune Infiltration in Pre-Eclampsia and Identify Novel Biomarkers for Pre-Eclampsia

Unveiling immune tolerance pathways in preeclampsia placenta: implications for molecular targets and discovery of potential biomarkers

Identification of Genetic and Immune Mechanisms Linking Preeclampsia and Endometrial Cancer: a Prognostic Model for Survival and Treatment Response